Moomoo AIのまとめ
On April 5, 2024, Novo Integrated Sciences, Inc. entered into a securities purchase agreement with Streeterville Capital, LLC, issuing a secured convertible promissory note with a principal sum of $6,210,000, maturing on April 8, 2025. The note includes an original issue discount of $660,000 and a 10.9% annual interest rate. Streeterville paid $5,500,000 for the note, with $50,000 withheld for transaction costs. Novo Integrated Sciences used the proceeds to repay outstanding promissory notes totaling $3,777,777.77. The note allows Streeterville to convert the debt into common stock under certain conditions and includes redemption rights starting October 8, 2024. The company also entered into a security agreement, granting Streeterville a security interest in all company assets. Subsidiaries Acenzia Inc. and Novo Healthnet Limited provided guarantees and security interests in their assets. The company is required to seek shareholder approval for the transaction within six months and must repay the note in cash if approval is not obtained within nine months. The agreement includes customary representations, warranties, covenants, and registration rights for the common stock underlying the note.
On April 5, 2024, Novo Integrated Sciences, Inc. entered into a securities purchase agreement with Streeterville Capital, LLC, issuing a secured convertible promissory note with a principal sum of $6,210,000, maturing on April 8, 2025. The note includes an original issue discount of $660,000 and a 10.9% annual interest rate. Streeterville paid $5,500,000 for the note, with $50,000 withheld for transaction costs. Novo Integrated Sciences used the proceeds to repay outstanding promissory notes totaling $3,777,777.77. The note allows Streeterville to convert the debt into common stock under certain conditions and includes redemption rights starting October 8, 2024. The company also entered into a security agreement, granting Streeterville a security interest in all company assets. Subsidiaries Acenzia Inc. and Novo Healthnet Limited provided guarantees and security interests in their assets. The company is required to seek shareholder approval for the transaction within six months and must repay the note in cash if approval is not obtained within nine months. The agreement includes customary representations, warranties, covenants, and registration rights for the common stock underlying the note.
2024年4月5日、Novo Integrated Sciences, Inc.はStreeterville Capital、LLCと証券購入契約を結び、$6,210,000の償還可能転換社債を発行し、2025年4月8日に満期となります。この債券には$660,000の割引優遇と10.9%の年利が含まれています。Streetervilleは、$50,000の取引費用を差し引いた$5,500,000で債券を購入しました。Novo Integrated Sciencesは、残高が$3,777,777.77に達する債券を償還するために受取金を使用しました。債券には、特定の条件の下でStreetervi...すべて展開
2024年4月5日、Novo Integrated Sciences, Inc.はStreeterville Capital、LLCと証券購入契約を結び、$6,210,000の償還可能転換社債を発行し、2025年4月8日に満期となります。この債券には$660,000の割引優遇と10.9%の年利が含まれています。Streetervilleは、$50,000の取引費用を差し引いた$5,500,000で債券を購入しました。Novo Integrated Sciencesは、残高が$3,777,777.77に達する債券を償還するために受取金を使用しました。債券には、特定の条件の下でStreetervilleが債務を普通株式に転換することができる権利が含まれ、2024年10月8日から償還権が発生します。会社はまた、Streetervilleに会社のすべての資産に対する担保権を付与するセキュリティ契約にも署名しました。子会社のAcenzia Inc.とNovo Healthnet Limitedは、それぞれ保証および担保権を提供しています。取引についての株主承認を6か月以内に求める義務があり、9か月以内に承認が得られない場合は現金による債務弁済が必要です。この契約には、債券に基づく普通株式の登録権を含む慣例的な表明、保証、規約、および登録権が含まれます。
役に立った
役に立たない
